preprint
<title>Abstract</title> The management of phytopathogenic fungal diseases in an ecofriendly way is an important agricultural challenge. This study evaluates the antifungal activity of mycogenic selenium nanoparticles (SeNPs), chitosan nanoparticles (NCT), and their composite against three phytopathogenic fungi: <italic>Alternaria alternata</italic>, <italic>Fusarium oxysporum</italic> and <italic>Fusarium verticilliodes</italic>. SeNPs were prepared by a previous biosynthesis method. Exposure to SeNPs altered fungal morphogenesis, significantly reducing biomass and sporulation. Transmission electron microscopy revealed SeNPs interactions with cell walls and damage to organelles, with intracellular SeNPs localization. Chitosan was produced from <italic>Rhizopus arrhizus</italic> yielding 0.52 g/L at 79.5% deacetylation. Fourier transform infrared and scanning electron microscopy characterized NCT and the SeNPs-NCT composite. SeNPs exhibited the strongest antifungal effects, completely inhibiting <italic>A. alternata</italic> and <italic>F. oxysporum</italic> growth at 12 ppm and <italic>F. verticilliodes</italic> at 25 ppm. NCT showed antifungal properties but lower efficacy, requiring 1000 ppm for complete inhibition. The SeNPs-NCT composite reduced activity versus SeNPs alone. This study demonstrates the antifungal potential of SeNPs and NCT against important plant pathogens. SeNPs interactions with fungal cells are also elucidated, providing insights into potential mechanisms of action such as cell wall embedment and organelle disruption.
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.21203/rs.3.rs-5100821/v1
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.